Aalto-born Surgify raises a €1.0M seed investment round

The Surgify Safety burr prevents the nerve and blood vessel injuries that are typically caused by other surgical drills.

A surgeon using the Surgify Safety Burr in a simulated surgery. Photo: Surgify

The technology can be easily used with existing surgical drills, and its usage does not require any additional training for the surgeon or the staff. The patent pending safety mechanism prevents the drill from damaging vital tissues, such as nerves or blood vessels. Besides neurosurgical applications, the innovation can be used in the future also in spine surgery and in the fields of orthopedics and dentistry.

“The technology has raised great interest amongst hospitals and surgeons globally. For example, we recently visited Harvard University’s teaching hospitals in Boston, and the reception was enthusiastic”, tells Visa Sippola, the CEO of Surgify.

The technology has been initially developed in cooperation between Aalto University and Department of Neurosurgery at Helsinki University Hospital. The company aims to bring the Safety Burr technology to the market in 2019. The company thereafter plans to initiate sales in the Nordic Countries, after which it will expand the business to global markets. In addition to the easy adoption process of the technology, the considerable reductions in costs and surgical complications are expected to positively affect the demand for the solution.

“Our core mission is to make bone surgery safer, as we believe that our technology has the potential to save lives in the future. The fact that we also bring clear cost savings to surgery will be of help in carrying out that mission – for example the complications caused by the current surgical drills cost over 4 billion euros each year globally”, Sippola explains.

The investors joining the startup’s second round of financing include a Finnish venture capital firm Butterfly Ventures, as well as Cascara Ventures from Belgium, Merkatura AB (Andreas Bunge) from Sweden and FRIIH GmBH (Dr. Michael Friebe) from Germany. The funding will be used to finalize the neurosurgical burr and to apply for a sales approval in Europe.

Read also: Safer bone surgery thanks to a technique patented at Aalto

Contact:

Visa Sippola
CEO, Surgify Medical
+358 50 353 1232
[email protected]

 

Related news

Kuva: Tuomas Uusheimo.
Research & Art Published:

EURO2022 conference to be hosted by Aalto University

Largest European conference in operations research and management science to be hosted in Otaniemi in July 2022
Falling Walls
Research & Art Published:

Win a trip to Berlin with ideas pitching competition

Falling Walls Lab Finland submission period closes soon, enter your research or business idea to be in a chance to compete in the international final
Matias Palva. Kuva: Mikko Raskinen.
Research & Art Published:

Matias Palva, Professor of Brain Signal Analytics, studies the mechanisms of the human mind and brain diseases

Understanding the brain mechanisms behind the diseases is important when developing targeted treatments
Nanocellulose bicycle Photo: Eeva Suorlahti
Cooperation, Press releases, Research & Art Published:

Tomorrow's Sustainable Lifestyles Showcased in Otaniemi

One of Helsinki Design Week's main events, Designs for a Cooler Planet, will showcase Aalto University's cross-cutting future prototypes, such as a nanocellulose bicycle, microbial headphones and Ioncell clothes
  • Published:
  • Updated:
Share
URL copied!